Cargando…
Low-Dose Acyclovir Prophylaxis for Varicella zoster Reactivation in Autologous Hematopoietic Cell Transplantation Recipients
Varicella zoster virus (VZV) reactivation after autologous hematopoietic cell transplantation (auto-HCT) may be observed in a quarter of patients. Currently, prophylactic use of acyclovir 800 mg twice daily or valacyclovir 500 mg twice daily is recommended for prophylaxis against VZV reactivation fo...
Autores principales: | Fei, Naomi, Shah, Nilay, Cumpston, Aaron, Wen, Sijin, Ross, Kelly G., Craig, Michael, Kanate, Abraham S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Atlantis Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432389/ https://www.ncbi.nlm.nih.gov/pubmed/34595417 http://dx.doi.org/10.2991/chi.d.190329.001 |
Ejemplares similares
-
442 Varicella zoster virus infection after allogeneic hematopoietic cell transplantation in Korean children under relatively short-term acyclovir prophylaxis
por: Han, Seung Beom, et al.
Publicado: (2014) -
Evaluation of Serum Posaconazole Concentrations in Patients with Hematological Malignancies Receiving Posaconazole Suspension Compared to the Delayed-Release Tablet Formulation
por: Belling, Morgan, et al.
Publicado: (2017) -
Immunogenicity of Inactivated Varicella Zoster Vaccine (ZV(IN)) in Autologous Hematopoietic Stem Cell Transplant (auto-HSCT) Recipients
por: Boeckh, Michael, et al.
Publicado: (2017) -
Varicella zoster virus infection after allogeneic hematopoietic cell transplantation in children using a relatively short duration of acyclovir prophylaxis: A retrospective study
por: Han, Seung Beom, et al.
Publicado: (2017) -
Delayed acyclovir therapy for disseminated varicella zoster in an adult kidney transplant recipient: a case report and literature review
por: Alsultan, Mohammad, et al.
Publicado: (2023)